Back to top

Can Merrimack Pharmaceuticals Inc. (MACK) Continue to Rise?

Read MoreHide Full Article
Although Merrimack Pharmaceuticals Inc. (MACK) is up over 26.5% in the past four weeks, investors may be concerned. After all, MACK is now in overbought territory, at least when looking at its RSI value of 84.5. If that wasn’t enough, investors should also note that Merrimack Pharmaceuticals Inc. possesses a Zacks Rank #4 (Sell), so if analyst perception is any guide, we could witness a slump in MACK shares before too long.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Merrimack Pharmaceuticals, Inc. (MACK) - free report >>

More from Zacks Tale of the Tape

You May Like